Genenta Science S.p.A. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value

Genenta Science S.p.A. (GNTA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of EUR 4.58 thousand as of 2025-12-31, per its 20-F filed 2026-04-01.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-04-01

2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 4.58K EUR.
2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 363.83K EUR.
2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 506.70K EUR.
2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 33.80K EUR.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
2025-12-31	4.58K EUR 20-F · filed 2026-04-01
2025-06-30	363.83K EUR 6-K · filed 2025-10-10
2024-12-31	506.70K EUR 20-F · filed 2026-04-01
2023-12-31	33.80K EUR 20-F · filed 2026-04-01
2023-06-30	255.01K EUR 6-K · filed 2023-10-20
2022-12-31	210.49K EUR 20-F · filed 2025-03-28
2022-06-30	29.88K EUR 6-K · filed 2022-10-25
2021-04-30	546.00 EUR 20-F · filed 2024-03-29
2020-12-31	584.13K EUR 6-K · filed 2022-10-25